182 related articles for article (PubMed ID: 21047778)
1. The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction.
Adak S; DeAndrade D; Pike LJ
J Biol Chem; 2011 Jan; 286(2):1545-55. PubMed ID: 21047778
[TBL] [Abstract][Full Text] [Related]
2. The membrane proximal disulfides of the EGF receptor extracellular domain are required for high affinity binding and signal transduction but do not play a role in the localization of the receptor to lipid rafts.
Macdonald J; Li Z; Su W; Pike LJ
Biochim Biophys Acta; 2006 Aug; 1763(8):870-8. PubMed ID: 16842869
[TBL] [Abstract][Full Text] [Related]
3. The membrane-proximal intracellular domain of the epidermal growth factor receptor underlies negative cooperativity in ligand binding.
Adak S; Yang KS; Macdonald-Obermann J; Pike LJ
J Biol Chem; 2011 Dec; 286(52):45146-55. PubMed ID: 22069315
[TBL] [Abstract][Full Text] [Related]
4. Mutagenesis reveals a role for epidermal growth factor receptor extracellular subdomain IV in ligand binding.
Saxon ML; Lee DC
J Biol Chem; 1999 Oct; 274(40):28356-62. PubMed ID: 10497195
[TBL] [Abstract][Full Text] [Related]
5. Asp-960/Glu-961 controls the movement of the C-terminal tail of the epidermal growth factor receptor to regulate asymmetric dimer formation.
Yang KS; Macdonald-Obermann JL; Piwnica-Worms D; Pike LJ
J Biol Chem; 2010 Jul; 285(31):24014-22. PubMed ID: 20507979
[TBL] [Abstract][Full Text] [Related]
6. Rational optimization of a bispecific ligand trap targeting EGF receptor family ligands.
Jin P; Zhang J; Beryt M; Turin L; Brdlik C; Feng Y; Bai X; Liu J; Jorgensen B; Shepard HM
Mol Med; 2009; 15(1-2):11-20. PubMed ID: 19048033
[TBL] [Abstract][Full Text] [Related]
7. Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation.
Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2014 Sep; 289(38):26178-26188. PubMed ID: 25086039
[TBL] [Abstract][Full Text] [Related]
8. A single ligand is sufficient to activate EGFR dimers.
Liu P; Cleveland TE; Bouyain S; Byrne PO; Longo PA; Leahy DJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10861-6. PubMed ID: 22699492
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
Gill K; Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system.
Macdonald JL; Pike LJ
Proc Natl Acad Sci U S A; 2008 Jan; 105(1):112-7. PubMed ID: 18165319
[TBL] [Abstract][Full Text] [Related]
11. The intracellular juxtamembrane domain of the epidermal growth factor (EGF) receptor is responsible for the allosteric regulation of EGF binding.
Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2009 May; 284(20):13570-13576. PubMed ID: 19336395
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S
Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050
[TBL] [Abstract][Full Text] [Related]
13. Allosteric regulation of epidermal growth factor (EGF) receptor ligand binding by tyrosine kinase inhibitors.
Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2018 Aug; 293(35):13401-13414. PubMed ID: 29997256
[TBL] [Abstract][Full Text] [Related]
14. Palmitoylation of the EGF receptor impairs signal transduction and abolishes high-affinity ligand binding.
Macdonald-Obermann JL; Pike LJ
Biochemistry; 2009 Mar; 48(11):2505-13. PubMed ID: 19196031
[TBL] [Abstract][Full Text] [Related]
15. Allosteric activation of preformed EGF receptor dimers by a single ligand binding event.
Purba ER; Saita EI; Akhouri RR; Öfverstedt LG; Wilken G; Skoglund U; Maruyama IN
Front Endocrinol (Lausanne); 2022; 13():1042787. PubMed ID: 36531494
[TBL] [Abstract][Full Text] [Related]
16. Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor.
Arkhipov A; Shan Y; Kim ET; Shaw DE
PLoS Comput Biol; 2014 Jul; 10(7):e1003742. PubMed ID: 25058506
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for negative cooperativity in growth factor binding to an EGF receptor.
Alvarado D; Klein DE; Lemmon MA
Cell; 2010 Aug; 142(4):568-79. PubMed ID: 20723758
[TBL] [Abstract][Full Text] [Related]
18. Serotonin 2A receptor disulfide bridge integrity is crucial for ligand binding to different signalling states but not for its homodimerization.
Iglesias A; Cimadevila M; la Fuente RA; Martí-Solano M; Cadavid MI; Castro M; Selent J; Loza MI; Brea J
Eur J Pharmacol; 2017 Nov; 815():138-146. PubMed ID: 28899696
[TBL] [Abstract][Full Text] [Related]
19. Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation.
Zhou M; Felder S; Rubinstein M; Hurwitz DR; Ullrich A; Lax I; Schlessinger J
Biochemistry; 1993 Aug; 32(32):8193-8. PubMed ID: 8347619
[TBL] [Abstract][Full Text] [Related]
20. Mechanics of EGF receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging.
Macdonald-Obermann JL; Piwnica-Worms D; Pike LJ
Proc Natl Acad Sci U S A; 2012 Jan; 109(1):137-42. PubMed ID: 22190492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
